Lumoxiti

From WikiMD.org
Jump to navigation Jump to search
Lumoxiti
TermLumoxiti
Short definitionLumoxiti (loo-MOK-sih-tee) A drug used to treat adults with hairy cell leukemia who have returned or not improved with at least two other systemic therapies, including treatment with a purine nucleoside analogue (a type of cancer drug). Lumoxiti contains a monoclonal antibody that attaches to a protein called CD22, which is found on B cells (a type of white blood cell) and some types of leukemia cells. 
TypeCancer terms
SpecialtyOncology
LanguageEnglish
SourceNCI
Comments


Lumoxiti - (pronounced) (loo-MOK-sih-tee) A drug used to treat adults with hairy cell leukemia who have returned or not improved with at least two other systemic therapies, including treatment with a purine nucleoside analogue (a type of cancer drug). Lumoxiti contains a monoclonal antibody that attaches to a protein called CD22, which is found on B cells (a type of white blood cell) and some types of leukemia cells. It also contains a bacterial toxin called PE38 that can help kill cancer cells. Lumoxiti is a type of immunotoxin. Also called anti-CD22 immunotoxin CAT-8015, CAT-8015 and moxetumomab pasudotox

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski